Experience with Vinorelbine in Patients with Breast Cancer and Hyperbilirubinaemia Secondary to Liver Metastases

Purpose: Patients with hepatic dysfunction as a consequence of breast cancer with liver metastases have a very poor prognosis and limited systemic treatment options [1]. Pharmacokinetic studies suggest vinorelbine can be administered safely in patients with hyperbilirubinaemia [2]; however, very few data are available on the efficacy of this approach.

Source: Clinical Oncology - July 8, 2020 Category: Radiology Authors: J. Howells, M. Gyi, E. Blaiklock, T. Gulliford, K. Bradley, J. Gale, C. Archer, C. Coyle Source Type: research